| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105994 Treatment of prostate cancer |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105983 Cytotoxic agents |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060105981 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1) |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105949 Pharmaceutical preparations and methods for inhibiting tumors |
| 05/18/2006 | US20060105946 Method for treating the central nervous system by administration of igf structural analogs |
| 05/18/2006 | US20060105430 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105403 Braca1/acc alpha molecular complexes, diagnostic and therapeutic applications |
| 05/18/2006 | US20060105386 17867, a novel human aminopeptidase |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060105333 Method for diagnosis of intestinal-type gastric tumors |
| 05/18/2006 | US20060105330 Diagnostics and remedies for malignant brain tumor |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060104999 Composition for solubilization of paclitaxel and preparation method thereof |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | US20060104981 Prophylactic/therapeutic agent for cancer |
| 05/18/2006 | US20060104974 CD147 binding molecules as therapeutics |
| 05/18/2006 | US20060104971 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 05/18/2006 | US20060104964 Recombinant sequence, its preparation and use |
| 05/18/2006 | US20060104956 gene expression inhibition; hairpin nucleic acids; for treatment of viral infections, tumors, and cancer |
| 05/18/2006 | DE19608751B4 Verwendung eines Adeno-assoziierten Virus-Vektors zur Steigerung der Immunogenität von Zellen Using an adeno-associated virus vector to enhance the immunogenicity of cells |
| 05/18/2006 | DE102004055284A1 Pharmaceutical composition containing phospholipid, sterol and negative charge carrier, useful in human or veterinary medicine for treating e.g. arthropod, protozoal and bacterial infections or tumors |
| 05/18/2006 | CA2587609A1 4-amino-5-oxo-8-phenyl-5h-pyrido[2,3-d]pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours |
| 05/18/2006 | CA2587369A1 Mutant interferon .alpha. proteins and use thereof |
| 05/18/2006 | CA2587336A1 Ptpase inhibitors and t-cell activators for treating cancer |
| 05/18/2006 | CA2587276A1 Nanoparticulate compositions of tubulin inhibitor compounds |
| 05/18/2006 | CA2587192A1 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 05/18/2006 | CA2587173A1 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | CA2586929A1 N,n'-diphenylurea derivatives suitable as kinase inhibitors |
| 05/18/2006 | CA2586781A1 Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation |
| 05/18/2006 | CA2586701A1 Lna oligonucleotides and the treatment of cancer |
| 05/18/2006 | CA2586679A1 Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| 05/18/2006 | CA2586661A1 Antibodies against tenascin-c |
| 05/18/2006 | CA2586375A1 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
| 05/18/2006 | CA2585660A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors |
| 05/18/2006 | CA2585446A1 Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level |
| 05/18/2006 | CA2585421A1 Conjugates with enhanced cell uptake activity |
| 05/18/2006 | CA2585310A1 5-heteroaryl thiazoles and their use as p13k inhibitors |
| 05/17/2006 | EP1657307A1 Oligonucleotides that induce the secretion of GM-CSF |
| 05/17/2006 | EP1657256A2 Compositions and methods for the treatment of tumor |
| 05/17/2006 | EP1657247A1 Steroidal compounds for inhibiting steroid sulphotase |
| 05/17/2006 | EP1657242A1 Imidazopyridine derivatives |
| 05/17/2006 | EP1657241A1 Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656952A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 05/17/2006 | EP1656951A1 Conjugates with enhanced cell uptake activity |
| 05/17/2006 | EP1656950A1 Immunotoxins directed against CD33 related surface antigens |
| 05/17/2006 | EP1656947A1 Preventive and/or remedy for hematopoietic tumor |
| 05/17/2006 | EP1656939A1 Use of melatonin in the manufacture of a medicament for treating cancer |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656380A2 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 05/17/2006 | EP1656376A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/17/2006 | EP1656160A1 Radioimmunoconjugates for targeted alpha therapy |
| 05/17/2006 | EP1656157A1 2-methylene-19-nor-vitamin d2 compounds |
| 05/17/2006 | EP1656147A1 Diflunisal for the treatment of cancer |
| 05/17/2006 | EP1656146A2 Mitotic kinesin inhibitors |
| 05/17/2006 | EP1656144A2 Trp-p8 active compounds and therapeutic treatment methods |
| 05/17/2006 | EP1656140A1 Mitotic kinesin inhibitors |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656129A2 Blockade of mtor to prevent a hormonal adaptive response |
| 05/17/2006 | EP1656124A1 Methods and compositions for the treatment of cancer |
| 05/17/2006 | EP1423391B1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 05/17/2006 | EP1377552B1 Metal complexes and therapeutic uses thereof |
| 05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1296711B1 Hpv-e7 for human papilloma virus treatment |
| 05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 05/17/2006 | EP1222300B1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1141235B1 (bifidobacterium) in the treatment of inflammatory disease |
| 05/17/2006 | EP1135515B1 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | EP0923941B1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 05/17/2006 | EP0807124B1 Monoclonal antibody against flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774448A Growth factor complexes and modulation of cell migration and growth |
| 05/17/2006 | CN1774446A Identification of N-alkylglycine trimers for induction of apoptosis |
| 05/17/2006 | CN1774444A Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/17/2006 | CN1774429A Medicinal composition |
| 05/17/2006 | CN1774254A Phosphate derivatives of pharmaceutical products |
| 05/17/2006 | CN1774253A Treatment of refractory tumors using epothilone derivatives |
| 05/17/2006 | CN1774249A Use of irinotecan for treatment of resistant breast cancer |
| 05/17/2006 | CN1774248A 联合治疗 Combination therapy |
| 05/17/2006 | CN1774243A Therapeutic compositions |
| 05/17/2006 | CN1774242A Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2 |
| 05/17/2006 | CN1772894A Small interference RNA inhibiting the expression of 1A6/DRIM gene and its action site |
| 05/17/2006 | CN1772768A Extracellular polysaccharide sulfate of nitzschia closterium and its prepn and application |